{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:47:15Z","timestamp":1778672835496,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bbr.2020.113045","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T03:34:39Z","timestamp":1607484879000},"page":"113045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Suppressing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on locomotor hyperactivity induced by different drugs of abuse"],"prefix":"10.1016","volume":"400","author":[{"given":"Carla","family":"Lobina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Maccioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lorrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Zaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Collu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro A.M.","family":"Carai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Brizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Mugnaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Luigi","family":"Gessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Corelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2020.113045_bib0005","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1021\/jm400144w","article-title":"Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor","volume":"56","author":"Mugnaini","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbr.2020.113045_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbr.2020.113045_bib0015","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00213-017-4644-3","article-title":"Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors","volume":"234","author":"Maccioni","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.alcohol.2018.05.007","article-title":"Anti-addictive properties of COR659 \u2013 additional pharmacological evidence and comparison with a series of novel analogues","volume":"75","author":"Maccioni","year":"2019","journal-title":"Alcohol"},{"key":"10.1016\/j.bbr.2020.113045_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40263-018-0596-3","article-title":"Potential of GABAB receptor positive allosteric modulators in the treatment of alcohol use disorder","volume":"33","author":"Maccioni","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2020.113045_bib0030","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2020_178","article-title":"GABAB receptors and alcohol use disorders: preclinical studies","author":"Holtyn","year":"2020","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2020.113045_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00213-003-1706-5","article-title":"Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats","volume":"173","author":"Smith","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2007.07.048","article-title":"Effects of GABAB receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination","volume":"574","author":"Filip","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.113045_bib0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.108.139204","article-title":"Positive modulation of GABAB receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats","volume":"326","author":"Paterson","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.113045_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00213-010-2119-x","article-title":"Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats","volume":"215","author":"Vlachou","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0055","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00213-017-4594-9","article-title":"KK-92A, a novel GABAB receptor positive allosteric modulator, attenuates nicotine self-administration and cue-induced nicotine seeking in rats","volume":"234","author":"Li","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2007.05.069","article-title":"Effects of GABAB receptor agents on cocaine priming, discrete contextual cue and food induced relapses","volume":"571","author":"Filip","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.113045_bib0065","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00213-018-4893-9","article-title":"Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction","volume":"235","author":"Vengeliene","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0070","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1369-1600.2010.00278.x","article-title":"The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward","volume":"16","author":"Halbout","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbr.2020.113045_bib0075","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/sj.npp.1300734","article-title":"The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat","volume":"30","author":"Slattery","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/adb.12688","article-title":"GABAB receptor positive allosteric modulators with different efficacies affect neuroadaptation to and self-administration of alcohol and cocaine","volume":"24","author":"de Miguel","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbr.2020.113045_bib0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbr.2010.08.034","article-title":"Administration of GABAB receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference","volume":"216","author":"Voigt","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.113045_bib0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1124\/jpet.106.116228","article-title":"GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens \u0394FosB accumulation","volume":"321","author":"Mombereau","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.113045_bib0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/sj.npp.1301102","article-title":"GABAB receptor-positive modulation decreases selective molecular and behavioral effects of cocaine","volume":"32","author":"Lhuillier","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1476-5381.2011.01301.x","article-title":"The GABAB receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice","volume":"163","author":"Wiero\u0144ska","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.113045_bib0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fpsyt.2011.00076","article-title":"Activation of the GABAB receptor prevents nicotine-induced locomotor stimulation in mice","volume":"2","author":"Lobina","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2020.113045_bib0110","doi-asserted-by":"crossref","unstructured":"M. Frankowska, E. Przegalioski, M. Filip, Targeting the GABAB receptor for the treatment of substance use disorder, G. Colombo GABAB Receptor, The Receptors 29, Springer International Publishing, Cham, Switzerland, 263-286.","DOI":"10.1007\/978-3-319-46044-4_14"},{"key":"10.1016\/j.bbr.2020.113045_bib0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.bbr.2020.113045_bib0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0074-7742(08)60669-8","article-title":"Neurochemical bases of locomotion and ethanol stimulant effects","volume":"39","author":"Phillips","year":"1996","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bbr.2020.113045_bib0125","article-title":"Assessment of abuse potential of drugs, Guidance for industry, FDA-2010-D-0026","author":"Food and Drug Administration","year":"2017","journal-title":"Center for Drug Evaluation and Research"},{"key":"10.1016\/j.bbr.2020.113045_bib0130","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S1734-1140(12)70955-6","article-title":"Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice","volume":"64","author":"Rog\u00f3\u017c","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2020.113045_bib0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0091-3057(87)90123-7","article-title":"Locomotor activity as a predictor of times and dosages for studies of nicotine\u2019s neurochemical actions","volume":"26","author":"Freeman","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2020.113045_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/0014-2999(93)91006-9","article-title":"Gliquidone, an ATP-dependent K+ channel antagonist, antagonizes morphine-induced hypermotility","volume":"239","author":"Oca\u00f1a","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.113045_bib0145","first-page":"1","article-title":"Locomotor activity and exploration","volume":"Vol. II","author":"Kelley","year":"1993"},{"key":"10.1016\/j.bbr.2020.113045_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105544","article-title":"The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives","author":"Ferlenghi","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bbr.2020.113045_bib0155","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0022-3565(25)13057-7","article-title":"Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists","volume":"253","author":"Kalivas","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2020.113045_bib0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbr.2015.10.039","article-title":"Differential roles of GABAB1 subunit isoforms on locomotor responses to acute and repeated administration of cocaine","volume":"298","author":"Jacobson","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.113045_bib0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002130000562","article-title":"Modification of d-amphetamine-induced responses by baclofen in rats","volume":"153","author":"Phillis","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/phrs.2000.0789","article-title":"Inhibition of baclofen on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity","volume":"43","author":"Woo","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbr.2020.113045_bib0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(01)02457-0","article-title":"Opiate-induced motor stimulation is regulated by \u03b3-aminobutyric acid type B receptors found in the ventral tegmental area in mice","volume":"317","author":"Leite-Morris","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2020.113045_bib0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s002130050987","article-title":"Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils","volume":"144","author":"Poncelet","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0185","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/bph.14473","article-title":"Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine","volume":"176","author":"Gobira","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2020.113045_bib0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbr.2014.05.029","article-title":"Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine","volume":"270","author":"Polissidis","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2020.113045_bib0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-007-0913-x","article-title":"Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats","volume":"198","author":"Kelsey","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0200","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.neuropharm.2004.08.008","article-title":"Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716","volume":"47","author":"Singh","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0205","doi-asserted-by":"crossref","unstructured":"M.P. Castelli, G.L. Gessa, Distribution and localization of the GABAB receptor, in: G. Colombo (Ed.), GABAB Receptor, The Receptors 29, Springer International Publishing, Cham, Switzerland, pp. 75-92.","DOI":"10.1007\/978-3-319-46044-4_5"},{"key":"10.1016\/j.bbr.2020.113045_bib0210","doi-asserted-by":"crossref","unstructured":"A.L. Lalive, C. L\u00fcscher, GABAB receptor functions in the mesolimbic dopamine system, in: G. Colombo (Ed.), GABAB Receptor, The Receptors 29, Springer International Publishing, Cham, Switzerland, pp. 129-154.","DOI":"10.1007\/978-3-319-46044-4_8"},{"key":"10.1016\/j.bbr.2020.113045_bib0215","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neuropharm.2005.03.016","article-title":"Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction","volume":"48","author":"Lupica","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2020.113045_bib0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbr.2020.113045_bib0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","article-title":"SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats","volume":"13","author":"Cohen","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2020.113045_bib0230","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/ejn.13248","article-title":"Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids","volume":"43","author":"Covey","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbr.2020.113045_bib0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neulet.2007.04.012","article-title":"The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food","volume":"419","author":"Melis","year":"2007","journal-title":"Neurosci. Lett."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820307440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820307440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:23:17Z","timestamp":1759065797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432820307440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":47,"alternative-id":["S0166432820307440"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2020.113045","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppressing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on locomotor hyperactivity induced by different drugs of abuse","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2020.113045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113045"}}